GARZI, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 224
NA - Nord America 140
AS - Asia 96
AF - Africa 2
SA - Sud America 1
Totale 463
Nazione #
IT - Italia 182
US - Stati Uniti d'America 138
SG - Singapore 54
CN - Cina 15
IN - India 10
GB - Regno Unito 6
ID - Indonesia 5
NO - Norvegia 5
BG - Bulgaria 4
TR - Turchia 4
DE - Germania 3
HK - Hong Kong 3
MK - Macedonia 3
PT - Portogallo 3
UA - Ucraina 3
CA - Canada 2
ES - Italia 2
FR - Francia 2
MA - Marocco 2
RO - Romania 2
RU - Federazione Russa 2
SE - Svezia 2
BE - Belgio 1
BO - Bolivia 1
EE - Estonia 1
FI - Finlandia 1
JP - Giappone 1
LT - Lituania 1
MY - Malesia 1
NL - Olanda 1
PH - Filippine 1
TH - Thailandia 1
VN - Vietnam 1
Totale 463
Città #
Singapore 42
Rome 27
Fairfield 18
Chandler 15
Ashburn 14
Milan 14
Turin 10
Florence 9
New York 9
Wilmington 9
Cambridge 6
San Paolo di Civitate 6
Catania 5
Jakarta 5
Padova 5
Cagliari 4
Istanbul 4
Lucera 4
Millbury 4
Princeton 4
Santa Clara 4
Sofia 4
Azzano Decimo 3
Hong Kong 3
Lawrence 3
Lisbon 3
London 3
Naples 3
Skopje 3
Woodbridge 3
Ann Arbor 2
Barcelona 2
Bari 2
Bonate Sopra 2
Cerignola 2
Cervia 2
Como 2
Fossano 2
Frosinone 2
Munich 2
Oderzo 2
Ottawa 2
Petriolo 2
Seattle 2
Sem 2
Tønsberg 2
Varese 2
Verdello 2
Verona 2
Viterbo 2
Andover 1
Angeles City 1
Avellino 1
Bangkok 1
Bergamo 1
Boston 1
Brunswick 1
Brussels 1
Casablanca 1
Castel di Sangro 1
Castelfranco di Sotto 1
Gorizia 1
Groningen 1
Hanoi 1
Helsinki 1
Houston 1
Hyderabad 1
Jacksonville 1
Los Angeles 1
Nashville 1
Oslo 1
Pescara 1
Pieve di Soligo 1
Portland 1
Pune 1
Rabat 1
San Diego 1
San Pietro in Lama 1
Stockholm 1
Sucre 1
Tallinn 1
Tokyo 1
Torrita di Siena 1
Totale 319
Nome #
Granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID): a multicenter retrospective study of patients from italian PID referral centers 172
Clinico-immunologic outcomes of HCV-cured cryoglobulinemia: lower relapse rate with interferon-based than interferon-free therapy 54
Health-related quality of life in common variable immunodeficiency Italian patients switched to remote assistance during the COVID-19 pandemic 53
Systemic allergic reactions induced by labile plant-food allergens. Seeking potential cofactors. A multicenter study 34
SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience 27
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters 22
Common and uncommon CT findings in CVID-related GL-ILD: correlations with clinical parameters, therapeutic decisions and potential implications in the differential diagnosis 22
Mortality in Severe Antibody Deficiencies Patients during the First Two Years of the COVID-19 Pandemic: Vaccination and Monoclonal Antibodies Efficacy 21
Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic 19
High Prevalence of Long COVID in Common Variable Immunodeficiency: An Italian Multicentric Study 18
Struggling with COVID-19 in adult inborn errors of immunity patients: a case series of combination therapy and multiple lines of therapy for selected patients 17
Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric Study 16
Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022 11
SARS-CoV-2 vaccination in primary antibody deficiencies: an overview on efficacy, immunogenicity, durability of immune response and safety 8
Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022 5
Totale 499
Categoria #
all - tutte 2.336
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.336


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 0 0 1 2
2020/202146 4 2 0 1 10 0 1 8 1 11 1 7
2021/202242 4 0 0 2 5 2 0 3 12 4 2 8
2022/202365 7 12 0 5 5 6 4 6 7 1 7 5
2023/2024207 1 16 6 17 10 30 10 10 8 21 48 30
2024/2025136 31 21 27 51 6 0 0 0 0 0 0 0
Totale 499